BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 48091)

  • 21. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study.
    Laurin J; Lindor KD; Crippin JS; Gossard A; Gores GJ; Ludwig J; Rakela J; McGill DB
    Hepatology; 1996 Jun; 23(6):1464-7. PubMed ID: 8675165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The treatment of essential hyperlipidemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:184-7. PubMed ID: 4918619
    [No Abstract]   [Full Text] [Related]  

  • 23. A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias.
    Tuomilehto J; Salonen J; Kuuisto P; Virtamo J; Manninen V; Mälkönen M
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):38-40. PubMed ID: 798195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The clinical and biochemical aspects of clofibrate].
    Ylikahri R; Kähönen M
    Duodecim; 1972; 88(10):688-99. PubMed ID: 5068884
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative studies on the reduction of lipids using clofibric acid and clofibrate in hyperlipoproteinemias].
    Schwartzkopff W; Hoffmann H; Kästner W
    Med Welt; 1975 Dec; 26(51):2308-15. PubMed ID: 177837
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of clofibrate on glucose tolerance and insulin secretion in patients with endogenous hypertriglyceridemia (author's transl)].
    Schwandt P; Weisweiler P; Neureuther G; Wilkening J
    MMW Munch Med Wochenschr; 1976 Mar; 118(12):351-4. PubMed ID: 177863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypolipemic activity of ITA 104].
    Vilageliu J; Zapatero MD; Bruseghini L
    Arch Farmacol Toxicol; 1978 Apr; 4(1):135-6. PubMed ID: 697379
    [No Abstract]   [Full Text] [Related]  

  • 28. [Long-term management of various hyperlipidemias using clofibrate].
    Studlar M; Pichler O; Kindler K
    Wien Med Wochenschr; 1975 Dec; 125(50-52):746-51. PubMed ID: 1229130
    [No Abstract]   [Full Text] [Related]  

  • 29. [Letter: Etofibrate and clofibrate in double blind study].
    Knipping W; Kaffarnik H; Schneider J; Haase W
    Dtsch Med Wochenschr; 1976 Apr; 101(16):627-9. PubMed ID: 770108
    [No Abstract]   [Full Text] [Related]  

  • 30. [Influence of a combined treatment using clofibrate and persantin persantinat on increased serum lipid levels].
    Hammerl H; Nebosis G; Pichler O; Studlar M
    Med Welt; 1973 Mar; 24(12):468-70. PubMed ID: 4700881
    [No Abstract]   [Full Text] [Related]  

  • 31. [Combination of clofibrate and phenformin in the treatment of endogenous hypertriglyceridaemia (author's transl)].
    Vogelberg KH
    Dtsch Med Wochenschr; 1976 Dec; 101(51):1868-71. PubMed ID: 1001205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of clofibrate.
    Hart A
    N Z Med J; 1978 Jun; 87(613):406. PubMed ID: 277806
    [No Abstract]   [Full Text] [Related]  

  • 33. [Changes in the spectrum of serum lipids following 3 months administration of clofibrate Spofa].
    Cagánova A; Cagan S
    Cesk Farm; 1971 Nov; 20(9):341-6. PubMed ID: 5136172
    [No Abstract]   [Full Text] [Related]  

  • 34. [Atherosclerosis, hyperlipidemia and clofibrate].
    Eisenberg S; Stein Y
    Harefuah; 1979 Jun; 96(12):677-8. PubMed ID: 520921
    [No Abstract]   [Full Text] [Related]  

  • 35. Clofibrate in the management of hyperlipidaemia.
    Drug Ther Bull; 1982 May; 20(11):41-3. PubMed ID: 7140522
    [No Abstract]   [Full Text] [Related]  

  • 36. [Modification of serum uric acid concentration under long-term therapy with the lipid-regulating drug Duolip].
    Scherhag R
    Fortschr Med; 1983 Sep; 101(36):1635-7. PubMed ID: 6629296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clofibrate and ischemic heart disease].
    Oye I
    Tidsskr Nor Laegeforen; 1973 Jan; 93(1):33-4. PubMed ID: 4691223
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of Aloe barbedensis & clofibrate on serum lipids in triton-induced hyperlipidaemia in Presbytis monkeys.
    Dixit VP; Joshi S
    Indian J Med Res; 1983 Sep; 78():417-21. PubMed ID: 6674162
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effects on the serum lipids of bis (hydroxy-2 ethylthio) 1,10 decane (LL 1558) and clofibrate, based on 91 cases of primary hyperlipoproteinemia].
    Rouffy J
    Sem Hop Ther; 1973 Jan; 49(1):31-6. PubMed ID: 4712022
    [No Abstract]   [Full Text] [Related]  

  • 40. Letter: Acute-on-chronic renal failure precipitated by clofibrate.
    Dosa S; Mallick NP; Slotki IN
    Lancet; 1976 Jan; 1(7953):250. PubMed ID: 55557
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.